Efficacy of methylene blue for on vasoplegic syndrome

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 224

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RCM-3-2_007

تاریخ نمایه سازی: 18 تیر 1398

Abstract:

Introduction: Administration of methylene blue has been proposed as a therapeutic strategy in the treatment of vasopelgic shock following cardiac surgery. Major aims of this systematic review were to evaluate the effect of methylene blue on mortality rate, duration of vasoplegic syndrome, and further complications of patients with vasoplegic syndrome following cardiac surgery. Methods: PubMed was searched to obtain the most relevant articles. All the randomized control trials and cohort studies were included.Result: A total of 54 articles were retrieved at the initial search. After studying the titles, abstracts, and full text of the articles, only five articles consisted of two randomized controlled trials (RCTs) and two observational studies were included.Discussion: Based on included RCTs, the mortality rate and duration of the disease decreased in patients applied methylene blue in the treatment of vasoplegic syndrome compared with those did not receive this medication.Conclusions: Bbased on included articles, application of methylene blue could be suggested as a treatment for vasoplegic syndrome, but further large multicenter RCTs are needed to certainly evaluate the efficacy of methylene blue.

Authors

Mohsen akhondi

Department of Anesthesiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Alireza Sabzevari

Department of Anesthesiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Shabnam Imannezhad

Department of Gynecology, School of Medicine, Mashhad University of Medical Science, Mashhad, Iran.

Ali Rahdari

Department of Anesthesiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome: ...
  • Levin MA, Lin HM, Castillo JG, et al. Early on-cardiopulmonary ...
  • Carrel T, Englberger L, Mohacsi P, et al. Low systemic ...
  • Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N ...
  • Argenziano M, Chen JM, Choudhri AF, et al. Management of ...
  • Shanmugam G. Vasoplegic syndrome--the role of methylene blue. Eur J ...
  • Levin RL, Degrange MA, Bruno GF, et al. Methylene blue ...
  • Ozal E, Kuralay E, Yildirim V, et al. Preoperative methylene ...
  • Leyh RG, Kofidis T, Struber M, et al. Methylene blue: ...
  • Weiner MM, Lin HM, Danforth D, et al. Methylene blue ...
  • Evora PR, Roselino CH, Schiaveto PM. Methylene blue in anaphylactic ...
  • Yiu P. Should methylene blue be the drug of choice ...
  • Gando S, Kameue T, Nanzaki S, et al. Participation of ...
  • Cheng X, Pang CC. Pressor and vasoconstrictor effects of methylene ...
  • Zhang H, Rogiers P, Preiser JC, Spapen H, Manikis P, ...
  • Weingartner R, Oliveira E, Oliveira ES, et al. Blockade of ...
  • نمایش کامل مراجع